Profit Or Loss [Abstract]

Captor Therapeutics S.A. - Filing #6064395

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
15 825 PLN
13 201 PLN
Other income
60,000 PLN
595,000 PLN
Profit (loss) from operating activities
38 967 PLN
73 016 PLN
Finance costs
503,000 PLN
594,000 PLN
Profit (loss) before tax
38 426 PLN
70 527 PLN
Tax expense (income)
0 PLN
57,000 PLN
Profit (loss) from continuing operations
38 426 PLN
70 584 PLN
Profit (loss)
38 426 PLN
70 584 PLN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
38 426 PLN
70 584 PLN
Profit (loss), attributable to non-controlling interests
0 PLN
0 PLN
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
825.00
1,519.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
825.00
1,480.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.